09/16/2025
3:30 PM | Abate Kristin (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2025
3:31 PM | Cheng Sohanya Roshan (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2025
3:32 PM | Karyopharm Therapeutics (Issuer)
Rangwala Reshma (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2025
3:33 PM | Karyopharm Therapeutics (Issuer)
Poulton Stuart (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2025
3:34 PM | Karyopharm Therapeutics (Issuer)
Mano Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2025
3:35 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2025
3:33 PM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2025
3:53 PM | Abate Kristin (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2025
11:12 AM | Karyopharm Therapeutics (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
| Form SCHEDULE 13G | |
08/11/2025
7:01 AM | Karyopharm Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/11/2025
6:31 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
08/11/2025
6:34 AM | Karyopharm Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/30/2025
3:56 PM | Karyopharm Therapeutics (Issuer)
Poulton Stuart (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2025
4:18 PM | Abate Kristin (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2025
8:34 AM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Karyopharm Therapeutics (Subject)
| Form SCHEDULE 13G | |
07/11/2025
6:28 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2025
3:28 PM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2025
3:12 PM | Karyopharm Therapeutics (Issuer)
Oliger Christy J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2025
3:13 PM | Karyopharm Therapeutics (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2025
3:15 PM | Karyopharm Therapeutics (Issuer)
Su Zhen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2025
3:40 PM | Karyopharm Therapeutics (Issuer)
Rangwala Reshma (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/14/2025
7:24 AM | Karyopharm Therapeutics (Filer)
| Form ARS | |
04/14/2025
7:15 AM | Karyopharm Therapeutics (Filer)
| Form DEF 14A | |
04/14/2025
7:19 AM | Karyopharm Therapeutics (Filer)
| Form DEFA14A | |
04/10/2025
4:23 PM | Affinity Asset Advisors, LLC (Filed by)
Karyopharm Therapeutics (Subject)
| Form SCHEDULE 13G | |
03/06/2025
3:13 PM | Karyopharm Therapeutics (Issuer)
Mano Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:48 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:49 PM | Abate Kristin (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:46 PM | Karyopharm Therapeutics (Issuer)
Mano Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
6:32 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2025
6:36 AM | Karyopharm Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/12/2025
8:36 AM | Adage Capital Management, L.P. (Filed by)
Karyopharm Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/05/2025
3:16 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
7:34 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
3:03 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:07 PM | Karyopharm Therapeutics (Issuer)
Macomber Lori (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
6:08 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
3:35 PM | Karyopharm Therapeutics (Filer)
| Form PRE 14A | |
12/05/2024
3:15 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
6:09 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
2:50 PM | Karyopharm Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
|
11/06/2024
3:06 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
7:02 AM | Karyopharm Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/05/2024
6:47 AM | Karyopharm Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024
6:41 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
10:49 AM | Karyopharm Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/31/2024
6:41 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
8:30 AM | HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Karyopharm Therapeutics (Subject)
| Form SC 13G | |
